Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 66

1.

Noncalcemic actions of vitamin D receptor ligands.

Nagpal S, Na S, Rathnachalam R.

Endocr Rev. 2005 Aug;26(5):662-87. Epub 2005 Mar 29. Review.

PMID:
15798098
2.

Vitamin D receptor as a drug discovery target.

Pinette KV, Yee YK, Amegadzie BY, Nagpal S.

Mini Rev Med Chem. 2003 May;3(3):193-204. Review.

PMID:
12570835
3.

Vitamin D analogs: mechanism of action and therapeutic applications.

Nagpal S, Lu J, Boehm MF.

Curr Med Chem. 2001 Nov;8(13):1661-79. Review.

PMID:
11562285
4.

Vitamin D receptor ligands for osteoporosis.

Cheskis BJ, Freedman LP, Nagpal S.

Curr Opin Investig Drugs. 2006 Oct;7(10):906-11. Review.

PMID:
17086935
5.

The importance of stereochemistry on the actions of vitamin D.

Chiellini G, DeLuca HF.

Curr Top Med Chem. 2011;11(7):840-59. Review.

PMID:
21291397
6.

Vitamin D receptor modulators for inflammation and cancer.

Yee YK, Chintalacharuvu SR, Lu J, Nagpal S.

Mini Rev Med Chem. 2005 Aug;5(8):761-78. Review.

PMID:
16101412
7.

Cellular and molecular mechanisms involved in the action of vitamin D analogs targeting vitiligo depigmentation.

Birlea SA, Costin GE, Norris DA.

Curr Drug Targets. 2008 Apr;9(4):345-59. Review.

PMID:
18393827
8.

Immunomodulatory effects of vitamin D receptor ligands in autoimmune diseases.

Adorini L.

Int Immunopharmacol. 2002 Jun;2(7):1017-28. Review.

PMID:
12188026
9.

Therapeutic applications for novel non-hypercalcemic vitamin D receptor ligands.

Choi M, Makishima M.

Expert Opin Ther Pat. 2009 May;19(5):593-606. doi: 10.1517/13543770902877717. Review.

PMID:
19441936
10.

[Current Topics on Vitamin D. Nonsecosteroidal vitamin D mudulators and prospects for their thepapeutic application].

Makishima M.

Clin Calcium. 2015 Mar;25(3):403-11. doi: CliCa. Review. Japanese.

PMID:
25716814
11.

Current status of vitamin D signaling and its therapeutic applications.

Carlberg C, Molnar F.

Curr Top Med Chem. 2012;12(6):528-47. Review.

PMID:
22242854
12.

Vitamin D endocrine system and psoriasis vulgaris--review of the literature.

Rucević I, Barisić-Drusko V, Glavas-Obrovac L, Stefanić M.

Acta Dermatovenerol Croat. 2009;17(3):187-92. Review.

PMID:
19818218
13.

Vitamin D receptor agonists: opportunities and challenges in drug discovery.

Takahashi T, Morikawa K.

Curr Top Med Chem. 2006;6(12):1303-16. Review.

PMID:
16848744
14.

[Recent progress of study on vitamin D analogs].

Kittaka A, Saito N, Takano M.

Clin Calcium. 2006 Jul;16(7):1154-65. Review. Japanese.

PMID:
16816476
15.

Update on biological actions of 1alpha,25(OH)2-vitamin D3 (rapid effects) and 24R,25(OH)2-vitamin D3.

Norman AW, Okamura WH, Bishop JE, Henry HL.

Mol Cell Endocrinol. 2002 Nov 29;197(1-2):1-13. Review.

PMID:
12431790
16.

Multifunctional and potent roles of the 3-hydroxypropoxy group provide eldecalcitol's benefit in osteoporosis treatment.

Ono Y.

J Steroid Biochem Mol Biol. 2014 Jan;139:88-97. doi: 10.1016/j.jsbmb.2013.10.007. Epub 2013 Oct 16. Review.

PMID:
24139874
17.

The vitamin D hormone and its nuclear receptor: molecular actions and disease states.

Haussler MR, Haussler CA, Jurutka PW, Thompson PD, Hsieh JC, Remus LS, Selznick SH, Whitfield GK.

J Endocrinol. 1997 Sep;154 Suppl:S57-73. Review.

18.

Control of autoimmune diseases by the vitamin D endocrine system.

Adorini L, Penna G.

Nat Clin Pract Rheumatol. 2008 Aug;4(8):404-12. doi: 10.1038/ncprheum0855. Epub 2008 Jul 1. Review.

PMID:
18594491
19.

Vitamin D analogs: therapeutic applications and mechanisms for selectivity.

Brown AJ, Slatopolsky E.

Mol Aspects Med. 2008 Dec;29(6):433-52. doi: 10.1016/j.mam.2008.04.001. Epub 2008 May 1. Review.

PMID:
18554710
20.

Vitamin D receptor ligands: the impact of crystal structures.

Carlberg C, Molnár F, Mouriño A.

Expert Opin Ther Pat. 2012 Apr;22(4):417-35. doi: 10.1517/13543776.2012.673590. Epub 2012 Mar 27. Review.

PMID:
22449247

Supplemental Content

Support Center